Home Comparison of Two Different Methods for Measurement of Phenylalanine in Dried Blood Spots
Article
Licensed
Unlicensed Requires Authentication

Comparison of Two Different Methods for Measurement of Phenylalanine in Dried Blood Spots

  • Adriana Rivero , Juan Antonio Allué , Ana Grijalba , Mercedes Palacios and Sergio García Merlo
Published/Copyright: June 1, 2005
Become an author with De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Volume 38 Issue 8

Abstract

Phenylketonuria is an inherited metabolic disorder caused by a defect in the hydroxylation of phenylalanine. Newborn screening is crucial for the diagnosis and treatment of this disease. A phenylalanine dehydrogenase-coupled enzymatic assay (Quantase) in microtiter plates for the screening of phenylketonuria was evaluated and compared with our routine method based on the modified fluorometric McCaman method. The test exhibited a linear calibration curve with a good slope as well as sufficient imprecision (< 10%), recovery (99.23 ± 4.86%) and limit of detection (54.5 μmol/l). One hundred and ninety dried blood spots were analysed by this enzymatic method and compared with McCaman's. Although Quantase (Teknovas, Bilbao, Spain) showed a phenylalanine mean level in dried blood spot 18.2 μmol/l higher than that obtained with our routine method, the agreement between both techniques was considered acceptable.

:
Published Online: 2005-06-01
Published in Print: 2000-08-21

Copyright © 2000 by Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. Changes of the Coagulation and Fibrinolysis System in Malignancy: Their possible Impact on Future Diagnostic and Therapeutic Procedures
  2. Laboratory Support of the Clinical Nutrition Service
  3. A new Method for Fast Haptoglobin Phenotyping and Hemoglobin Binding Capacity Calculation Based on Capillary Zone Electrophoresis
  4. Apolipoprotein E Polymorphism and Serum Concentration in Alzheimer's Disease in Nine European Centres: the ApoEurope Study
  5. Association of the Apolipoprotein B Gene Polymorphisms with Cholesterol Levels and Response to Fluvastatin in Brazilian Individuals with High Risk for Coronary Heart Disease
  6. Antioxidant Status, Erythrocyte Membrane Lipid Peroxidation and Osmotic Fragility in Malignant Lymphoma Patients
  7. Determination of H+/K+-ATPase Activity in Human Gastric Biopsy Specimens
  8. European Cerebrospinal Fluid Consensus Group a TeamRoom (Lotus Notes)-Based Communication Network
  9. Automated Enzymatic Mitochondrial Antibody Assay for the Diagnosis of Primary Biliary Cirrhosis
  10. Study of IgM Aggregation in Serum of Patients with Macroglobulinemia
  11. Trace Element Reference Values in Serum Determined by Inductively Coupled Plasma Atomic Emission Spectrometry
  12. Comparison of Two Different Methods for Measurement of Phenylalanine in Dried Blood Spots
  13. Anti-β2-Glycoprotein I ELISA: Methodology, Determination of Cut-off Values in 434 Healthy Caucasians and Evaluation of Monoclonal Antibodies as Possible International Standards
  14. Comparative Multicentre Study of a Panel of Thyroid Tests Using Different Automated Immunoassay Platforms and Specimens at High Risk of Antibody Interference
  15. A G5569A HFE Gene Polymorphism that Interferes in DNA Tests for Genetic Haemochromatosis: Who Needs to Be Re-tested?
  16. Evaluation of the Conformity of Human Growth Hormone. Concentrations Measured with the DPC Immulite® and the Nichols® Advantage™ Assays
  17. Atlas of Atherosclerosis – Progression and Regression. By Herbert C. Stary
  18. Liver Disease and Laboratory Medicine. By Ian McFarlane, Adrian Bomford and Roy Sherwood
Downloaded on 28.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2000.110/html
Scroll to top button